Mission Statement

The Journal of Hematology Oncology Pharmacy (JHOP) is an independent, peer-reviewed journal founded in 2011 to provide hematology and oncology pharmacists and other healthcare professionals in these fields with high-quality information relevant to hematologic and oncologic conditions to help them optimize drug therapy for patients. It is published 6 times a year, with a special issue in March devoted to the abstracts presented at the Hematology/Oncology Pharmacy Association conference, called the Annual Issue of HOPA Abstracts.

JHOP is an open access journal that requires no fee to be published or to access the content online or in print.

A user license manages the reuse of JHOP articles under the following license: Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND). Authors retain rights to reuse their articles for personal and scholarly purposes (eg, for classroom teaching or presentations at conferences, as an addition to a book or compilation of articles, or to publicly share the final published article on a noncommercial website) without permission from JHOP. Readers may use JHOP articles for noncommercial purposes; however, commercial uses are not allowed without permission from the JHOP editorial team.

Journal of Hematology Oncology Pharmacy

Co-Editors-in-Chief

Val R. Adams, PharmD, BCOP, FCCP, FHOPA
Associate Professor, Pharmacy
Program Director, PGY2 Specialty Residency
Hematology/Oncology, University of Kentucky College of Pharmacy
Lexington, KY

Patrick J. Medina, PharmD, BCOP, FHOPA
Senior Field Medical Director
BeOne Medicines

The Journal of Hematology Oncology Pharmacy (JHOP) seeks to provide hematology and oncology pharmacy practitioners and other hematology oncology professionals with high-quality peer-reviewed information to help them optimize drug therapy for patients.

The journal provides a source for translational and practice-based research, including through Original Research articles, Case Reports, and Case Series. Our goal is that these articles will answer the clinically relevant pharmacy questions that remain unaddressed—many of which do not require a million-dollar extramural grant to answer.

JHOP also includes Review Articles focusing on drugs and disease states, including basic science reviews of the complex molecular biology of cancer. Although there is a plethora of review articles available to clinicians, most do not have a pharmacy focus, and few if any focus on the molecular biology of cancer and the complex signaling pathways associated with malignancy. As new classes of drugs emerge, discussion about the pathways and the drugs targeting the pathways will help pharmacists understand the drug classes based on their pharmacology.

As pharmacy practice and research become integral to improving the clinical care of cancer patients as well as to expanding the research literature in contemporary oncology pharmacy, new avenues are necessary to ensure this information gets disseminated to the profession. Thus, JHOP is also an excellent source for articles delving into Practical Issues in Pharmacy Management, which are focused on real-world issues involving logistics, economics, and other practice-related topics. Finally, Symptom Management Overviews explore a specific symptom, its etiology, and management.

We as the co-editors-in-chief hope that JHOP will fill many unmet needs by providing another avenue for the publication of peer-reviewed, high-quality pharmacy literature that is intended for hematology oncology practitioners. We encourage you to submit manuscripts for consideration and to provide your feedback on what would enhance the value of this publication for you and your colleagues.

Talk to the JHOP Editors by contacting us here.

Journal of Hematology Oncology Pharmacy is included in EBSCO Research Databases and is a Member of Alliance for Audited Media.

Amplity
2050 Cabot Blvd. West, Suite 110
Langhorne, PA 19047